BioLineRx (NASDAQ:BLRX) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of BioLineRx (NASDAQ:BLRX – Get Free Report) in a report issued on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. Several other brokerages also recently commented on BLRX. HC Wainwright lifted their target price on shares of BioLineRx from $9.00 to $26.00 and […]
